Stocks
CVS Health Corporation (CVS) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 6.00% | 3.83% | 5.09% | 3.67% | 2.45% | 2.73% | ||
| Changes by years, y/y, % | 0pp | -2pp | +1pp | -1pp | -1pp | -17.4% | |||
CVS Health Corporation. EBITDA margin, %
CVS Health Corporation. EBITDA margin, changes, pp
CVS Health Corporation (CVS) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 4.82% | 3.62% | -1.52% | 3.11% | 5.80% | 2.73% | |
| Changes by years, y/y, % | +1pp | -1pp | -4pp | -1pp | +1pp | |||
| Changes by quarters, q/q, % | +1pp | -1pp | -5pp | +5pp | +3pp | |||
